Back to top
more

MEDNAX, Inc. (MD)

(Real Time Quote from BATS)

$29.85 USD

29.85
141,132

+0.73 (2.51%)

Updated Aug 2, 2021 12:41 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy25.57%
2Buy19.14%
3Hold10.74%
4Sell6.46%
5Strong Sell3.16%
S&P50011.27%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 10% (24 out of 252)

Industry: Medical - Hospital

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Balance Sheet

Research for MD

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for MEDNAX, Inc. falls in the month of December.

All items in Millions except Per Share data.

12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Assets          
Cash & Equivalents 1,229 187 79 70 67
Receivables 242 499 542 504 495
Notes Receivable 0 0 0 0 0
Inventories 0 0 0 0 0
Other Current Assets 79 45 36 53 25
Total Current Assets 1,549 732 657 627 587
Net Property & Equipment 76 94 133 124 103
Investments & Advances 0 0 70 81 79
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 54 162 0 0 0
Intangibles 1,505 2,985 4,971 4,924 4,514
Deposits & Other Assets 107 90 103 112 57
Total Assets 3,348 4,146 5,935 5,867 5,339
Liabilities & Shareholders Equity 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Notes Payable 0 0 0 0 0
Accounts Payable 423 512 469 438 408
Current Portion Long-Term Debt 2 0 0 1 22
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 0 0 0 0 0
Income Taxes Payable 0 7 31 92 19
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 444 542 500 531 449
Mortgages 0 0 0 0 0
Deferred Taxes/Income 62 58 131 148 228
Convertible Debt 0 0 0 0 0
Long-Term Debt 1,743 1,730 1,974 1,851 1,684
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 311 250 241 270 218
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 2,600 2,647 2,847 2,801 2,579
Shareholders Equity 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Preferred Stock 0 0 0 0 0
Common Stock (Par) 1 1 1 1 1
Capital Surplus 1,029 988 993 1,017 974
Retained Earnings -286 510 2,094 2,048 1,786
Other Equity 4 0 0 0 0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 748 1,499 3,088 3,066 2,761
Total Liabilities & Shareholder's Equity 3,348 4,146 5,935 5,867 5,339
Total Common Equity 748 1,499 3,088 3,066 2,761
Shares Outstanding 85.60 84.30 89.40 93.60 93.60
Book Value Per Share 8.74 17.78 34.54 32.76 29.50

Fiscal Year End for MEDNAX, Inc. falls in the month of December.

All items in Millions except Per Share data.

6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020
Assets          
Cash & Equivalents NA 370 1,229 376 223
Receivables NA 265 242 290 410
Notes Receivable NA 0 0 0 0
Inventories NA 0 0 0 0
Other Current Assets NA 30 79 985 55
Total Current Assets NA 665 1,549 1,651 688
Net Property & Equipment NA 81 76 79 98
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 71 54 63 61
Intangibles NA 1,504 1,505 1,508 2,365
Deposits & Other Assets NA 110 107 65 98
Total Assets NA 2,484 3,348 3,425 3,387
Liabilities & Shareholders Equity 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020
Notes Payable NA 0 0 0 0
Accounts Payable NA 306 423 389 361
Current Portion Long-Term Debt NA 2 2 2 1
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 0 0 0 0
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 0 0 79 0
Total Current Liabilities NA 327 444 488 384
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 62 62 64 69
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 997 1,743 1,742 1,737
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 311 285 314
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 1,717 2,600 2,620 2,561
Shareholders Equity 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 1 1 1 1
Capital Surplus NA 1,032 1,029 1,024 1,005
Retained Earnings NA -269 -286 -222 -179
Other Equity NA 3 4 2 0
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 767 748 805 827
Total Liabilities & Shareholder's Equity NA 2,484 3,348 3,425 3,387
Total Common Equity 0 767 748 805 827
Shares Outstanding 86.20 86.20 85.60 85.40 85.40
Book Value Per Share 0.00 8.90 8.74 9.43 9.68